Back to results
US 8,784,825 B2Granted
Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
AssigneeTaiga Biotechnologies, Inc.
InventorsYosef Refaeli, Brian Curtis Turner
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response.
Claims16
A composition for modulating an immune system, comprising:
- (a) a fusion peptide comprising:
- (i) a transporter peptide sequence;
- (ii) a MYC polypeptide sequence;
- and, optionally,
- (iii) one or more molecules that link the transporter peptide sequence and the MYC polypeptide sequence;
- (b) a pharmacologically acceptable excipient;
- and
- (c) an antigenic moiety.
5 more elements
Dependencies are inferred from the claim text.